STOCK TITAN

[8-K] HeartSciences Inc. Warrant Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Navitas Semiconductor Corporation (NVTS) filed an 8-K to inform investors that its sole supplier of gallium nitride (GaN) wafers, Taiwan Semiconductor Manufacturing Company (TSMC), will cease GaN production in July 2027. In response, Navitas is accelerating supply-chain diversification.

The company disclosed an expanded collaboration with Powerchip Semiconductor Manufacturing Corporation (PSMC). Key milestones are:

  • Q4 2025: qualification of initial devices on PSMC wafers
  • H1 2026: start of mass production of 100 V GaN products
  • Next 12-24 months: full transition of 650 V GaN devices from TSMC to PSMC

Navitas is also identifying and qualifying additional suppliers to further diversify its wafer sources and improve operational flexibility. The company believes the multi-vendor strategy will reduce single-source risk ahead of TSMC’s exit. No financial metrics, capacity commitments, or cost implications were provided in the filing. The information was furnished under Item 7.01 (Regulation FD) and is therefore not deemed “filed” for liability purposes.

Investors should weigh the strategic positives of diversification against the execution risks of qualifying new foundry partners within the stated timeframe.

Navitas Semiconductor Corporation (NVTS) ha presentato un modulo 8-K per informare gli investitori che il suo unico fornitore di wafer di nitruro di gallio (GaN), Taiwan Semiconductor Manufacturing Company (TSMC), cesserà la produzione di GaN nel luglio 2027. In risposta, Navitas sta accelerando la diversificazione della catena di approvvigionamento.

L'azienda ha annunciato una collaborazione ampliata con Powerchip Semiconductor Manufacturing Corporation (PSMC). Le tappe principali sono:

  • Q4 2025: qualificazione dei primi dispositivi su wafer PSMC
  • Primo semestre 2026: inizio della produzione di massa dei prodotti GaN a 100 V
  • Nei prossimi 12-24 mesi: completa transizione dei dispositivi GaN a 650 V da TSMC a PSMC

Navitas sta inoltre identificando e qualificando fornitori aggiuntivi per diversificare ulteriormente le fonti di wafer e migliorare la flessibilità operativa. L'azienda ritiene che la strategia multi-fornitore ridurrà il rischio di dipendenza da un solo fornitore in vista dell'uscita di TSMC. Nel documento non sono stati forniti dati finanziari, impegni di capacità o implicazioni sui costi. L'informazione è stata fornita ai sensi del Punto 7.01 (Regolamento FD) e pertanto non è considerata "depositata" ai fini di responsabilità legale.

Gli investitori dovrebbero valutare i vantaggi strategici della diversificazione rispetto ai rischi di esecuzione legati alla qualificazione di nuovi partner di fonderia entro i tempi indicati.

Navitas Semiconductor Corporation (NVTS) presentó un formulario 8-K para informar a los inversionistas que su único proveedor de obleas de nitruro de galio (GaN), Taiwan Semiconductor Manufacturing Company (TSMC), cesará la producción de GaN en julio de 2027. En respuesta, Navitas está acelerando la diversificación de su cadena de suministro.

La compañía reveló una colaboración ampliada con Powerchip Semiconductor Manufacturing Corporation (PSMC). Los hitos clave son:

  • 4º trimestre 2025: calificación de los primeros dispositivos en obleas de PSMC
  • 1er semestre 2026: inicio de la producción en masa de productos GaN de 100 V
  • Próximos 12-24 meses: transición completa de dispositivos GaN de 650 V de TSMC a PSMC

Navitas también está identificando y calificando proveedores adicionales para diversificar aún más sus fuentes de obleas y mejorar la flexibilidad operativa. La empresa considera que la estrategia de múltiples proveedores reducirá el riesgo de dependencia de una sola fuente antes de la salida de TSMC. No se proporcionaron métricas financieras, compromisos de capacidad ni implicaciones de costos en el informe. La información fue suministrada bajo el Punto 7.01 (Regulación FD) y, por lo tanto, no se considera "presentada" para propósitos de responsabilidad legal.

Los inversionistas deben sopesar los beneficios estratégicos de la diversificación frente a los riesgos de ejecución de calificar nuevos socios de fundición dentro del plazo establecido.

Navitas Semiconductor Corporation (NVTS)는 투자자들에게 자사의 유일한 갈륨 나이트라이드(GaN) 웨이퍼 공급업체인 대만 반도체 제조 회사(TSMC)가 2027년 7월에 GaN 생산을 중단할 예정임을 알리기 위해 8-K 보고서를 제출했습니다. 이에 대응하여 Navitas는 공급망 다각화를 가속화하고 있습니다.

회사는 Powerchip Semiconductor Manufacturing Corporation (PSMC)과의 협력을 확대했다고 밝혔습니다. 주요 일정은 다음과 같습니다:

  • 2025년 4분기: PSMC 웨이퍼에서 초기 장치 인증
  • 2026년 상반기: 100V GaN 제품 대량 생산 시작
  • 향후 12-24개월: 650V GaN 장치의 TSMC에서 PSMC로 완전 전환

Navitas는 또한 웨이퍼 공급원을 더욱 다양화하고 운영 유연성을 향상시키기 위해 추가 공급업체를 발굴하고 인증하는 작업을 진행 중입니다. 회사는 다중 공급업체 전략이 TSMC 퇴출에 앞서 단일 공급원 위험을 줄일 것으로 보고 있습니다. 보고서에는 재무 지표, 생산 능력 약정 또는 비용 영향에 대한 내용은 포함되지 않았습니다. 이 정보는 항목 7.01(규제 FD)에 따라 제공되었으며, 법적 책임 목적상 "제출"된 것으로 간주되지 않습니다.

투자자들은 다각화의 전략적 이점과 명시된 기간 내에 새로운 파운드리 파트너를 인증하는 실행 위험을 신중히 고려해야 합니다.

Navitas Semiconductor Corporation (NVTS) a déposé un formulaire 8-K pour informer les investisseurs que son unique fournisseur de plaquettes en nitrure de gallium (GaN), Taiwan Semiconductor Manufacturing Company (TSMC), cessera la production de GaN en juillet 2027. En réponse, Navitas accélère la diversification de sa chaîne d'approvisionnement.

L'entreprise a annoncé une collaboration élargie avec Powerchip Semiconductor Manufacturing Corporation (PSMC). Les étapes clés sont :

  • 4e trimestre 2025 : qualification des premiers dispositifs sur plaquettes PSMC
  • 1er semestre 2026 : début de la production de masse des produits GaN 100 V
  • 12 à 24 prochains mois : transition complète des dispositifs GaN 650 V de TSMC vers PSMC

Navitas identifie également et qualifie d'autres fournisseurs afin de diversifier davantage ses sources de plaquettes et d'améliorer sa flexibilité opérationnelle. L'entreprise estime que la stratégie multi-fournisseurs réduira le risque lié à une source unique avant la sortie de TSMC. Aucun indicateur financier, engagement de capacité ou implication de coûts n'a été communiqué dans le dépôt. L'information a été fournie en vertu de l'article 7.01 (Régulation FD) et n'est donc pas considérée comme "déposée" aux fins de responsabilité juridique.

Les investisseurs doivent peser les avantages stratégiques de la diversification contre les risques d'exécution liés à la qualification de nouveaux partenaires de fonderie dans les délais indiqués.

Navitas Semiconductor Corporation (NVTS) hat ein 8-K eingereicht, um Investoren darüber zu informieren, dass ihr einziger Lieferant von Galliumnitrid (GaN) Wafern, die Taiwan Semiconductor Manufacturing Company (TSMC), die GaN-Produktion im Juli 2027 einstellen wird. Als Reaktion darauf beschleunigt Navitas die Diversifizierung der Lieferkette.

Das Unternehmen gab eine erweiterte Zusammenarbeit mit Powerchip Semiconductor Manufacturing Corporation (PSMC) bekannt. Wichtige Meilensteine sind:

  • Q4 2025: Qualifizierung erster Geräte auf PSMC-Wafern
  • H1 2026: Beginn der Massenproduktion von 100 V GaN-Produkten
  • In den nächsten 12-24 Monaten: vollständiger Übergang der 650 V GaN-Geräte von TSMC zu PSMC

Navitas identifiziert und qualifiziert zudem zusätzliche Lieferanten, um die Waferquellen weiter zu diversifizieren und die operative Flexibilität zu verbessern. Das Unternehmen ist der Ansicht, dass die Multi-Lieferanten-Strategie das Risiko einer Einzelquelle vor dem Ausstieg von TSMC verringert. Im Bericht wurden keine finanziellen Kennzahlen, Kapazitätszusagen oder Kostenfolgen angegeben. Die Informationen wurden unter Punkt 7.01 (Regulation FD) bereitgestellt und gelten daher nicht als "eingereicht" im haftungsrechtlichen Sinne.

Investoren sollten die strategischen Vorteile der Diversifizierung gegen die Ausführungsrisiken abwägen, die mit der Qualifizierung neuer Foundry-Partner innerhalb des angegebenen Zeitrahmens verbunden sind.

Positive
  • New foundry partnership: Navitas secured PSMC as an alternative GaN wafer source with mass production slated for H1 2026.
  • Advance notice: TSMC’s 2027 exit provides a two-year window for orderly transition, reducing immediate disruption risk.
  • Diversification strategy: Company is actively qualifying additional suppliers, aiming to enhance operational flexibility and reduce single-source dependence.
Negative
  • Supply-chain disruption risk: TSMC, the current sole supplier of GaN wafers, will stop production in July 2027.
  • Execution uncertainty: Successful qualification and ramp-up at PSMC are not guaranteed; delays could jeopardize product availability.
  • Lack of financial detail: Filing contains no information on cost structure, capacity commitments, or potential margin impact from the supplier shift.

Insights

TL;DR: Supply-chain risk offset by new PSMC deal; financial impact unknown—overall neutral.

TSMC’s withdrawal removes Navitas’ single-source security, but the two-year notice plus PSMC agreement offers a credible mitigation path. Qualification in Q4 2025 and mass production in H1 2026 leave a cushion before the July 2027 cutoff. Still, the company discloses no volume, pricing, or capex details, so margin effects remain unclear. Because GaN wafers are core to Navitas’ revenue, successful execution is material; failure could constrain shipments. Given the balanced opportunity and risk, I view the disclosure as neutral for valuation until more data surface.

TL;DR: Loss of sole supplier is a structural negative; execution risk high—slightly negative impact.

TSMC is a premier foundry with proven GaN yields; replacing that capacity is non-trivial. PSMC’s GaN experience is less established, and qualification cycles can slip. Even a 12-month delay would compress the buffer ahead of TSMC’s July 2027 shut-off. Furthermore, multiphase voltage products (100 V vs 650 V) require distinct process optimizations, potentially elongating ramp time. Without firm second-source agreements, Navitas still faces concentration risk. I assign a −1 impact rating, reflecting elevated supply-chain uncertainty that could pressure customer confidence and long-term gross margins.

Navitas Semiconductor Corporation (NVTS) ha presentato un modulo 8-K per informare gli investitori che il suo unico fornitore di wafer di nitruro di gallio (GaN), Taiwan Semiconductor Manufacturing Company (TSMC), cesserà la produzione di GaN nel luglio 2027. In risposta, Navitas sta accelerando la diversificazione della catena di approvvigionamento.

L'azienda ha annunciato una collaborazione ampliata con Powerchip Semiconductor Manufacturing Corporation (PSMC). Le tappe principali sono:

  • Q4 2025: qualificazione dei primi dispositivi su wafer PSMC
  • Primo semestre 2026: inizio della produzione di massa dei prodotti GaN a 100 V
  • Nei prossimi 12-24 mesi: completa transizione dei dispositivi GaN a 650 V da TSMC a PSMC

Navitas sta inoltre identificando e qualificando fornitori aggiuntivi per diversificare ulteriormente le fonti di wafer e migliorare la flessibilità operativa. L'azienda ritiene che la strategia multi-fornitore ridurrà il rischio di dipendenza da un solo fornitore in vista dell'uscita di TSMC. Nel documento non sono stati forniti dati finanziari, impegni di capacità o implicazioni sui costi. L'informazione è stata fornita ai sensi del Punto 7.01 (Regolamento FD) e pertanto non è considerata "depositata" ai fini di responsabilità legale.

Gli investitori dovrebbero valutare i vantaggi strategici della diversificazione rispetto ai rischi di esecuzione legati alla qualificazione di nuovi partner di fonderia entro i tempi indicati.

Navitas Semiconductor Corporation (NVTS) presentó un formulario 8-K para informar a los inversionistas que su único proveedor de obleas de nitruro de galio (GaN), Taiwan Semiconductor Manufacturing Company (TSMC), cesará la producción de GaN en julio de 2027. En respuesta, Navitas está acelerando la diversificación de su cadena de suministro.

La compañía reveló una colaboración ampliada con Powerchip Semiconductor Manufacturing Corporation (PSMC). Los hitos clave son:

  • 4º trimestre 2025: calificación de los primeros dispositivos en obleas de PSMC
  • 1er semestre 2026: inicio de la producción en masa de productos GaN de 100 V
  • Próximos 12-24 meses: transición completa de dispositivos GaN de 650 V de TSMC a PSMC

Navitas también está identificando y calificando proveedores adicionales para diversificar aún más sus fuentes de obleas y mejorar la flexibilidad operativa. La empresa considera que la estrategia de múltiples proveedores reducirá el riesgo de dependencia de una sola fuente antes de la salida de TSMC. No se proporcionaron métricas financieras, compromisos de capacidad ni implicaciones de costos en el informe. La información fue suministrada bajo el Punto 7.01 (Regulación FD) y, por lo tanto, no se considera "presentada" para propósitos de responsabilidad legal.

Los inversionistas deben sopesar los beneficios estratégicos de la diversificación frente a los riesgos de ejecución de calificar nuevos socios de fundición dentro del plazo establecido.

Navitas Semiconductor Corporation (NVTS)는 투자자들에게 자사의 유일한 갈륨 나이트라이드(GaN) 웨이퍼 공급업체인 대만 반도체 제조 회사(TSMC)가 2027년 7월에 GaN 생산을 중단할 예정임을 알리기 위해 8-K 보고서를 제출했습니다. 이에 대응하여 Navitas는 공급망 다각화를 가속화하고 있습니다.

회사는 Powerchip Semiconductor Manufacturing Corporation (PSMC)과의 협력을 확대했다고 밝혔습니다. 주요 일정은 다음과 같습니다:

  • 2025년 4분기: PSMC 웨이퍼에서 초기 장치 인증
  • 2026년 상반기: 100V GaN 제품 대량 생산 시작
  • 향후 12-24개월: 650V GaN 장치의 TSMC에서 PSMC로 완전 전환

Navitas는 또한 웨이퍼 공급원을 더욱 다양화하고 운영 유연성을 향상시키기 위해 추가 공급업체를 발굴하고 인증하는 작업을 진행 중입니다. 회사는 다중 공급업체 전략이 TSMC 퇴출에 앞서 단일 공급원 위험을 줄일 것으로 보고 있습니다. 보고서에는 재무 지표, 생산 능력 약정 또는 비용 영향에 대한 내용은 포함되지 않았습니다. 이 정보는 항목 7.01(규제 FD)에 따라 제공되었으며, 법적 책임 목적상 "제출"된 것으로 간주되지 않습니다.

투자자들은 다각화의 전략적 이점과 명시된 기간 내에 새로운 파운드리 파트너를 인증하는 실행 위험을 신중히 고려해야 합니다.

Navitas Semiconductor Corporation (NVTS) a déposé un formulaire 8-K pour informer les investisseurs que son unique fournisseur de plaquettes en nitrure de gallium (GaN), Taiwan Semiconductor Manufacturing Company (TSMC), cessera la production de GaN en juillet 2027. En réponse, Navitas accélère la diversification de sa chaîne d'approvisionnement.

L'entreprise a annoncé une collaboration élargie avec Powerchip Semiconductor Manufacturing Corporation (PSMC). Les étapes clés sont :

  • 4e trimestre 2025 : qualification des premiers dispositifs sur plaquettes PSMC
  • 1er semestre 2026 : début de la production de masse des produits GaN 100 V
  • 12 à 24 prochains mois : transition complète des dispositifs GaN 650 V de TSMC vers PSMC

Navitas identifie également et qualifie d'autres fournisseurs afin de diversifier davantage ses sources de plaquettes et d'améliorer sa flexibilité opérationnelle. L'entreprise estime que la stratégie multi-fournisseurs réduira le risque lié à une source unique avant la sortie de TSMC. Aucun indicateur financier, engagement de capacité ou implication de coûts n'a été communiqué dans le dépôt. L'information a été fournie en vertu de l'article 7.01 (Régulation FD) et n'est donc pas considérée comme "déposée" aux fins de responsabilité juridique.

Les investisseurs doivent peser les avantages stratégiques de la diversification contre les risques d'exécution liés à la qualification de nouveaux partenaires de fonderie dans les délais indiqués.

Navitas Semiconductor Corporation (NVTS) hat ein 8-K eingereicht, um Investoren darüber zu informieren, dass ihr einziger Lieferant von Galliumnitrid (GaN) Wafern, die Taiwan Semiconductor Manufacturing Company (TSMC), die GaN-Produktion im Juli 2027 einstellen wird. Als Reaktion darauf beschleunigt Navitas die Diversifizierung der Lieferkette.

Das Unternehmen gab eine erweiterte Zusammenarbeit mit Powerchip Semiconductor Manufacturing Corporation (PSMC) bekannt. Wichtige Meilensteine sind:

  • Q4 2025: Qualifizierung erster Geräte auf PSMC-Wafern
  • H1 2026: Beginn der Massenproduktion von 100 V GaN-Produkten
  • In den nächsten 12-24 Monaten: vollständiger Übergang der 650 V GaN-Geräte von TSMC zu PSMC

Navitas identifiziert und qualifiziert zudem zusätzliche Lieferanten, um die Waferquellen weiter zu diversifizieren und die operative Flexibilität zu verbessern. Das Unternehmen ist der Ansicht, dass die Multi-Lieferanten-Strategie das Risiko einer Einzelquelle vor dem Ausstieg von TSMC verringert. Im Bericht wurden keine finanziellen Kennzahlen, Kapazitätszusagen oder Kostenfolgen angegeben. Die Informationen wurden unter Punkt 7.01 (Regulation FD) bereitgestellt und gelten daher nicht als "eingereicht" im haftungsrechtlichen Sinne.

Investoren sollten die strategischen Vorteile der Diversifizierung gegen die Ausführungsrisiken abwägen, die mit der Qualifizierung neuer Foundry-Partner innerhalb des angegebenen Zeitrahmens verbunden sind.

false --04-30 0001468492 0001468492 2025-06-27 2025-06-27 0001468492 us-gaap:CommonStockMember 2025-06-27 2025-06-27 0001468492 HSCSW:WarrantsMember 2025-06-27 2025-06-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 27, 2025

 

HEARTSCIENCES INC.

(Exact name of Registrant as Specified in Its Charter)

  

Texas   001-41422   26-1344466
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

550 Reserve Street, Suite 360    
Southlake, Texas   76092
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (682) 237-7781

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   HSCS   The NASDAQ Stock Market LLC
Warrants   HSCSW   The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On June 27, 2025, in connection with certain recent changes to the Texas Business Organizations Code (“TBOC”) and in light of Texas law, the Board of Directors of HeartSciences Inc. (the “Company”) adopted certain amendments to the Company’s Bylaws (the “Bylaws”) in order to:

 

(i)add a new section to provide for a jury trial waiver for “internal entity claims” as defined in the TBOC;

 

(ii)add a new section to adopt an ownership threshold requiring any shareholder or group of shareholders to hold shares of common stock sufficient to meet an ownership threshold of at least 3% of the Company’s issued and outstanding shares in order to institute or maintain a derivative proceeding; and

 

(iii)make technical revisions to clarify the scope of the exclusive forum provision.

 

The Bylaw amendments, adopted in accordance with Texas law, became effective on June 27, 2025.

 

The foregoing description is qualified in its entirety by reference to the amended Bylaws filed as Exhibit 3.1 to this Report.

 

Item 9.01 Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit No.   Description
     
3.1*   Third Amended and Restated Bylaws of HeartSciences Inc. 
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

*Filed herewith.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HeartSciences Inc.
     
Date: July 1, 2025 By: /s/ Danielle Watson
  Name:  Danielle Watson
  Title: Chief Financial Officer

 

 

2

 

 

FAQ

Why did Navitas (NVTS) file this 8-K?

To disclose that TSMC will end GaN wafer production in July 2027 and outline Navitas' plans to transition supply to Powerchip and other foundries.

What action is TSMC taking that affects Navitas?

TSMC will cease gallium nitride wafer production in July 2027, eliminating Navitas' current sole wafer source.

How is Navitas mitigating the loss of its sole GaN wafer supplier?

Navitas expanded collaboration with Powerchip, expects device qualification in Q4 2025 and mass production in H1 2026, and is seeking additional suppliers.

When will Powerchip begin mass production of GaN wafers for Navitas?

Initial mass production of 100 V GaN products is expected in the first half of 2026.

What is the timeline to transition 650 V GaN devices to Powerchip?

Navitas targets a complete shift of 650 V GaN devices from TSMC to Powerchip within the next 12-24 months.

Does the filing include financial guidance or cost estimates?

No. The 8-K does not provide any financial metrics, cost projections, or margin impact related to the supplier transition.
HeartSciences Inc

NASDAQ:HSCSW

HSCSW Rankings

HSCSW Latest News

HSCSW Stock Data

1.75M
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
SOUTHLAKE